Sanochemia: Notice of Allowance for patent application on photodynamic diagnosis in the US

To improve the treatment of bladder cancer, Sanochemia has developed Vidon® (PVP-Hypericin) for its photodynamic diagnosis. The product allows significantly improved tumor-detection and shows an excellent safety profile. The US patent protects Vidon® until 2035.

Sorry, this entry is only available in German!

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)